Significance of Mitochondrial Protein Post-translational Modifications in Pathophysiology of Brain Injury

Overview

Journal Transl Stroke Res

Publisher Springer

Date 2017 Sep 23

PMID 28936802

Citations 21

Authors

Nina Klimova

Aaron Long

Tibor Kristian

Affiliations

Soon will be listed here.

Abstract

Mitochondria are complex organelles that undergo constant fusion and fission in order to adapt to the ever-changing cellular environment. The fusion/fission proteins, localized in the inner and outer mitochondrial membrane, play critical roles under pathological conditions such as acute brain injury and neurodegenerative diseases. Post-translational modifications of these proteins tightly regulate their function and activity, ultimately impacting mitochondrial dynamics and their efficiency to generate ATP. The individual post-translational modifications that are known to affect mitochondrial dynamics include SUMOylation, ubiquitination, phosphorylation, S-nitrosylation, acetylation, O-linked N-acetyl-glucosamine glycosylation, ADP-ribosylation, and proteolytic cleavage. Under stress or pathologic conditions, several of these modifications are activated leading to a complex regulatory mechanism that shifts the state of the mitochondrial network. The main goal is to accommodate and adapt the cellular bioenergetics metabolism to the energetic demand of the new extra- and/or intracellular environment. Understanding the complex relationship between these modifications on fusion and fission proteins in particular pathologic stress or diseases can provide new promising therapeutic targets and treatment approaches. Here, we discuss the specific post-translational modifications of mitochondrial fusion/fission proteins under pathologic conditions and their impact on mitochondrial dynamics.

Citing Articles

The mitochondria as a potential therapeutic target in cerebral I/R injury.

Fang S, Huang W, Qu X, Chai W Front Neurosci. 2025; 18():1500647.

PMID: 39844858 PMC: 11752919. DOI: 10.3389/fnins.2024.1500647.

Sexual Dimorphism of Ethanol-Induced Mitochondrial Dynamics in Purkinje Cells.

Khatoon R, Fick J, Elesinnla A, Waddell J, Kristian T Int J Mol Sci. 2025; 25(24).

PMID: 39769476 PMC: 11678447. DOI: 10.3390/ijms252413714.

Bendless is essential for PINK1-Park mediated Mitofusin degradation under mitochondrial stress caused by loss of LRPPRC.

Cheramangalam R, Anand T, Pandey P, Balasubramanian D, Varghese R, Singhal N PLoS Genet. 2023; 19(4):e1010493.

PMID: 37098042 PMC: 10162545. DOI: 10.1371/journal.pgen.1010493.

Brain ethanol metabolism and mitochondria.

Waddell J, McKenna M, Kristian T Curr Top Biochem Res. 2023; 23:1-13.

PMID: 36873619 PMC: 9980429.

Deciphering deamidation and isomerization in therapeutic proteins: Effect of neighboring residue.

Irudayanathan F, Zarzar J, Lin J, Izadi S MAbs. 2022; 14(1):2143006.

PMID: 36377085 PMC: 9673968. DOI: 10.1080/19420862.2022.2143006.

References

Wang H, Song P, Du L, Tian W, Yue W, Liu M . Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease. J Biol Chem. 2011; 286(13):11649-58. PMC: 3064217. DOI: 10.1074/jbc.M110.144238. View

Ishihara N, Fujita Y, Oka T, Mihara K . Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 2006; 25(13):2966-77. PMC: 1500981. DOI: 10.1038/sj.emboj.7601184. View

Zunino R, Braschi E, Xu L, McBride H . Translocation of SenP5 from the nucleoli to the mitochondria modulates DRP1-dependent fission during mitosis. J Biol Chem. 2009; 284(26):17783-95. PMC: 2719417. DOI: 10.1074/jbc.M901902200. View

Owens K, Park J, Schuh R, Kristian T . Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury. Transl Stroke Res. 2013; 4(6):618-34. DOI: 10.1007/s12975-013-0278-x. View

Geisler S, Holmstrom K, Skujat D, Fiesel F, Rothfuss O, Kahle P . PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol. 2010; 12(2):119-31. DOI: 10.1038/ncb2012. View

Martin S, Wilkinson K, Nishimune A, Henley J . Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci. 2007; 8(12):948-59. PMC: 3314512. DOI: 10.1038/nrn2276. View

Garcia-Bonilla L, Moore J, Racchumi G, Zhou P, Butler J, Iadecola C . Inducible nitric oxide synthase in neutrophils and endothelium contributes to ischemic brain injury in mice. J Immunol. 2014; 193(5):2531-7. PMC: 4147670. DOI: 10.4049/jimmunol.1400918. View

Scott I, Webster B, Li J, Sack M . Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1. Biochem J. 2012; 443(3):655-61. PMC: 7461726. DOI: 10.1042/BJ20120118. View

Hochrainer K, Jackman K, Anrather J, Iadecola C . Reperfusion rather than ischemia drives the formation of ubiquitin aggregates after middle cerebral artery occlusion. Stroke. 2012; 43(8):2229-35. PMC: 3404229. DOI: 10.1161/STROKEAHA.112.650416. View

10.

Faraco G, Pancani T, Formentini L, Mascagni P, Fossati G, Leoni F . Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol. 2006; 70(6):1876-84. DOI: 10.1124/mol.106.027912. View

11.

van der Veen A, Ploegh H . Ubiquitin-like proteins. Annu Rev Biochem. 2012; 81:323-57. DOI: 10.1146/annurev-biochem-093010-153308. View

12.

Liu W, Tian F, Kurata T, Morimoto N, Abe K . Dynamic changes of mitochondrial fusion and fission proteins after transient cerebral ischemia in mice. J Neurosci Res. 2012; 90(6):1183-9. DOI: 10.1002/jnr.23016. View

13.

Anand R, Wai T, Baker M, Kladt N, Schauss A, Rugarli E . The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J Cell Biol. 2014; 204(6):919-29. PMC: 3998800. DOI: 10.1083/jcb.201308006. View

14.

Fu J, Yu H, Chiu S, Mirando A, Maruyama E, Cheng J . Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration. PLoS Genet. 2014; 10(10):e1004579. PMC: 4191884. DOI: 10.1371/journal.pgen.1004579. View

15.

Norvell A, McMahon S . Cell biology. Rise of the rival. Science. 2010; 327(5968):964-5. DOI: 10.1126/science.1187159. View

16.

Yildirim F, Gertz K, Kronenberg G, Harms C, Fink K, Meisel A . Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. Exp Neurol. 2008; 210(2):531-42. DOI: 10.1016/j.expneurol.2007.11.031. View

17.

Baburamani A, Hurling C, Stolp H, Sobotka K, Gressens P, Hagberg H . Mitochondrial Optic Atrophy (OPA) 1 Processing Is Altered in Response to Neonatal Hypoxic-Ischemic Brain Injury. Int J Mol Sci. 2015; 16(9):22509-26. PMC: 4613321. DOI: 10.3390/ijms160922509. View

18.

Yonashiro R, Ishido S, Kyo S, Fukuda T, Goto E, Matsuki Y . A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO J. 2006; 25(15):3618-26. PMC: 1538564. DOI: 10.1038/sj.emboj.7601249. View

19.

Stiburek L, Cesnekova J, Kostkova O, Fornuskova D, Vinsova K, Wenchich L . YME1L controls the accumulation of respiratory chain subunits and is required for apoptotic resistance, cristae morphogenesis, and cell proliferation. Mol Biol Cell. 2012; 23(6):1010-23. PMC: 3302729. DOI: 10.1091/mbc.E11-08-0674. View

20.

Kasashima K, Sumitani M, Satoh M, Endo H . Human prohibitin 1 maintains the organization and stability of the mitochondrial nucleoids. Exp Cell Res. 2008; 314(5):988-96. DOI: 10.1016/j.yexcr.2008.01.005. View